Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1960 1
1961 2
1972 1
1991 1
1997 1
1998 1
2000 1
2003 2
2005 3
2006 5
2007 4
2008 3
2009 1
2011 2
2012 2
2013 5
2014 2
2015 1
2016 2
2017 4
2018 1
2020 3
2021 3
2022 2
2023 2
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D; EXPLORER-HCM study investigators. Olivotto I, et al. Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29. Lancet. 2020. PMID: 32871100 Clinical Trial.
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
Maron MS, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Coats CJ, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Abraham TP; SEQUOIA-HCM Investigators. Maron MS, et al. N Engl J Med. 2024 May 30;390(20):1849-1861. doi: 10.1056/NEJMoa2401424. Epub 2024 May 13. N Engl J Med. 2024. PMID: 38739079 Clinical Trial.
Anthracycline cardiotoxicity.
Menna P, Paz OG, Chello M, Covino E, Salvatorelli E, Minotti G. Menna P, et al. Among authors: paz og. Expert Opin Drug Saf. 2012 May;11 Suppl 1:S21-36. doi: 10.1517/14740338.2011.589834. Epub 2011 Jun 2. Expert Opin Drug Saf. 2012. PMID: 21635149 Review.
Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial.
Lee MMY, Masri A, Nassif ME, Barriales-Villa R, Abraham TP, Claggett BL, Coats CJ, Gimeno JR, Kulac IJ, Landsteiner I, Ma C, Maron MS, Olivotto I, Owens AT, Solomon SD, Veselka J, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Lewis GD; SEQUOIA-HCM Investigators. Lee MMY, et al. JAMA Cardiol. 2024 Nov 1;9(11):990-1000. doi: 10.1001/jamacardio.2024.2781. JAMA Cardiol. 2024. PMID: 39230885 Free PMC article. Clinical Trial.
Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
Coats CJ, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N, Choudhury L, Claggett B, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Lee MMY, Lewis GD, Ma CS, Maron MS, Miao ZM, Michels M, Olivotto I, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins H, Jacoby DL, German P, Heitner SB, Kupfer S, Lutz JD, Malik FI, Meng L, Wohltman A, Abraham TP; SEQUOIA‐HCM Investigators *. Coats CJ, et al. J Am Heart Assoc. 2024 Aug 6;13(15):e035993. doi: 10.1161/JAHA.124.035993. Epub 2024 Jul 26. J Am Heart Assoc. 2024. PMID: 39056349 Free article. Clinical Trial.
V-EMF treatment of facial scar: First results.
Veronese S, Beatini A, Urbani C, Lanza E, Paz OM, Saussaye Y, Lomuto M, Sbarbati A. Veronese S, et al. Among authors: paz om. J Tissue Viability. 2022 Nov;31(4):614-618. doi: 10.1016/j.jtv.2022.07.006. Epub 2022 Jul 15. J Tissue Viability. 2022. PMID: 35853796
Transatlantic flight: Not only jet lag.
Paz O, Teodorovich N, Kogan Y, Swissa M. Paz O, et al. Heart Rhythm. 2017 Jul;14(7):1099-1101. doi: 10.1016/j.hrthm.2017.03.033. Epub 2017 Mar 28. Heart Rhythm. 2017. PMID: 28363442 No abstract available.
Parastomal Hernia, Risky Zone & Prophilactic Mesh.
De Keersmacker G, Beckers R, Heindryckx E, Kyle-Leinhase I, Pletinckx P, Claeys D, Muysoms F, Hernando LB, Ureña MA, Monclús JL, Del Valle AR, Montes DM, Pavón CC, Ceinos CJ, Cidoncha AC, Quindós PL, Franklin M, Hernandez M, Glover M, Glass J, Adedeiji A, Molina E, De La Paz O, Lalan J, Arias L, Tamayo Y, Mykytiuk S, Vlasov V, Mykytiuk O, Vlasova K, Köhler G, Pallwein-Prettner L, Luketina RR, Koch OO, Emmanuel K, Fang ZX, Ren F, Zhou JP, Liu DC, Tian J, Tu C, Winder J, Juza R, Pauli E, Chukwumah C, Meehan L, Bilkhu A, Anwar S, Bertoglio C, Magistro C, De Martini P, Lo Conte D, Di Lernia S, Ferrari G, Pugliese R, Köckerling F, Bellomo MP, Bona A, Borasi A, Borreca D, Filippa C, Manfredi S, De Paolis P, Lysenko R, Zuvela M, Galun D. De Keersmacker G, et al. Among authors: de la paz o. Hernia. 2015 Apr;19 Suppl 1:S25-31. doi: 10.1007/BF03355322. Hernia. 2015. PMID: 26518816 No abstract available.
56 results